Pleural Involvement Upon Relapse of Myeloma Responding to Daratumumab Plus Carfilzomib: A Case Presentation and Literature Review.

Uslu, Atilla; Seval, Güldane Cengiz; Merter, Mustafa; Dalva, Klara; Beksaç, Meral

Uslu, Atilla; Seval, Güldane Cengiz; Merter, Mustafa; Dalva, Klara; Beksaç, Meral.

Affiliation

Uslu A; Hematology Department, Ankara University School of Medicine, Ankara, Turkey.
Seval GC; Hematology Department, Ankara University School of Medicine, Ankara, Turkey.
Merter M; Hematology Department, Ankara University School of Medicine, Ankara, Turkey.
Dalva K; Hematology Department, Ankara University School of Medicine, Ankara, Turkey.
Beksaç M; Hematology Department, Ankara University School of Medicine, Ankara, Turkey. Electronic address: beksac@medicine.ankara.edu.tr.

Clin Lymphoma Myeloma Leuk ; 21(3): e267-e271, 2021 03.

Article in En | MEDLINE | ID: mdl-33380380

Subject(s)

Antineoplastic Combined Chemotherapy Protocols/therapeutic use; Multiple Myeloma/pathology; Pleural Neoplasms/drug therapy; Pleural Neoplasms/secondary; Aged; Antibodies, Monoclonal/administration & dosage; Antineoplastic Combined Chemotherapy Protocols/adverse effects; Disease Management; Humans; Immunophenotyping; Male; Multiple Myeloma/diagnostic imaging; Oligopeptides/administration & dosage; Pleural Neoplasms/diagnosis; Positron Emission Tomography Computed Tomography; Radiography, Thoracic; Tomography, X-Ray Computed; Treatment Outcome

Key words

Carfilzomib; Daratumumab; Extramedullary plasmacytoma; Flow cytometry; Pleural infiltration

Fulltext

XML

PubMed Links

Search on Google

Full text: 1 Collection: 01-internacional Database: MEDLINE Main subject: Pleural Neoplasms / Antineoplastic Combined Chemotherapy Protocols / Multiple Myeloma Type of study: Diagnostic_studies Limits: Aged / Humans / Male Language: En Journal: Clin Lymphoma Myeloma Leuk Journal subject: NEOPLASIAS Year: 2021 Type: Article Affiliation country: Turkey

Fulltext

XML

PubMed Links

Search on Google